GOLDMAN SACHS GROUP INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$8,000
-82.2%
11,344
-47.8%
0.00%
Q1 2022$45,000
-45.8%
21,726
-24.2%
0.00%
Q4 2021$83,000
-69.6%
28,671
-55.5%
0.00%
Q3 2021$273,000
-5.9%
64,468
+17.5%
0.00%
Q2 2021$290,000
-44.9%
54,882
-51.5%
0.00%
Q1 2021$526,000
+205.8%
113,104
+117.4%
0.00%
Q4 2020$172,000
-10.9%
52,024
-10.7%
0.00%
Q3 2020$193,000
-4.0%
58,260
-2.6%
0.00%
Q2 2020$201,000
+131.0%
59,791
+164.6%
0.00%
Q1 2020$87,000
+14.5%
22,596
+79.6%
0.00%
Q4 2019$76,000
-28.3%
12,582
-10.6%
0.00%
Q3 2019$106,000
+86.0%
14,068
+34.0%
0.00%
Q1 2019$57,000
-5.0%
10,495
-47.9%
0.00%
Q4 2018$60,000
-71.0%
20,139
-20.7%
0.00%
Q3 2018$207,000
-52.5%
25,385
-43.3%
0.00%
Q2 2018$436,000
+209.2%
44,785
+166.2%
0.00%
Q3 2017$141,000
-92.0%
16,821
-83.8%
0.00%
Q2 2017$1,763,000
-23.4%
103,905
-9.3%
0.00%
Q1 2017$2,303,000114,6000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders